SIGA
NASDAQ · Pharmaceuticals
Siga Technologies Inc
$5.08
+0.08 (+1.60%)
Financial Highlights (FY 2026)
Revenue
139.80M
Net Income
59.68M
Gross Margin
77.4%
Profit Margin
42.7%
Rev Growth
+1.2%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 77.4% | 77.4% | 56.0% | 56.0% |
| Operating Margin | 50.4% | 45.4% | 29.0% | 30.7% |
| Profit Margin | 42.7% | 40.6% | 29.9% | 24.4% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 139.80M | 138.09M | 139.54M | 109.98M |
| Gross Profit | 108.26M | 106.94M | 78.20M | 61.63M |
| Operating Income | 70.53M | 62.70M | 40.44M | 33.76M |
| Net Income | 59.68M | 53.05M | 41.70M | 26.81M |
| Gross Margin | 77.4% | 77.4% | 56.0% | 56.0% |
| Operating Margin | 50.4% | 45.4% | 29.0% | 30.7% |
| Profit Margin | 42.7% | 40.6% | 29.9% | 24.4% |
| Rev Growth | +1.2% | +1.2% | +11.8% | -1.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 102.11M | 85.97M |
| Total Equity | — | — | 302.28M | 324.83M |
| D/E Ratio | — | — | 0.34 | 0.26 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 77.21M | 72.45M | 62.48M | 50.98M |
| Free Cash Flow | — | — | 48.98M | 38.86M |